Congress at a Glance
Scientific Programme
Satellite Programme
Maps of the Venue
Search in:
 Papers, Programme or All
 Please use only plain characters
 (e.g., e, o, c and not è, ö or ç)
 		 
   
  Author   or    Free text  
   
  Author list  

  Personal Planner:
  Create a new login and password click here
Nb. Only your Personal Planner login is valid!
  Username Password  
   
 
  


Track:
  Treatment track
  Clinical research track
  Interface track
  Preclinical track
  Educational updates track

 
Scientific Programme Track:
View last minute changes Last minute changes
Back to overview
14:00-16:05 , Sunday, 31 August 2008
Symposia   

14:00-16:05
S.05:    Treatment track
TEM symposium - Cognitive impairment in affective disorders: a potential treatment target?
Chairs:  Julien Mendlewicz, Belgium
  George N. Papadimitriou, Greece
Auditorium

14:00
S.05.01  Cognitive impairment in affective disorders - what are the key issues?  Paper: S.05.01
I. Nicol Ferrier, United Kingdom
 

14:25
S.05.02  Bipolar disorder: neurodevelopmental or neurodegenerative  Paper: S.05.02
Anabel Martinez-Aran, Spain
 

14:50 View last minute changes
S.05.03  Cognition as an endophenotype in affective disorders  Paper: S.05.03
David C. Glahn, USA
David C. Glahn, USA will be replaced by Vicent Balanzá-Martinez, Spain
Title changes to: Cognition as an endophenotype in bipolar disorders
 

15:15
S.05.04  Cognition in mood disorders: from neuron to therapy  Paper: S.05.04
Allan H. Young, Canada
 

15:40
S.05.05  Future prospects on the biological and treatment correlates of cognitive deficits in affective disorders  Paper: S.05.05
Gin Malhi, Australia
 

14:00-16:05
S.06:    Clinical research track
Endophenotypes and spectrums in obsessive-compulsive disorder
Chairs:  Stefano Pallanti, Italy
  Joseph Zohar, Israel
Room J

14:00
S.06.01  The obsessive-compulsive spectrum disorders  Paper: S.06.01
Eric Hollander, USA
 

14:25 View last minute changes
S.06.02  Genetics of early onset in OCD  Paper: S.06.02
Susanne Walitza, Germany
Susanne Walitza, Germany will be replaced by Edna Grünblatt, Germany
 

14:50
S.06.03  Phenotyping OCD: new insights from animal behaviour  Paper: S.06.03
David Eilam, Israel
 

15:15
S.06.04  Neuropsychological endophenotypes in families with OCD  Paper: S.06.04
Naomi Fineberg, United Kingdom
 

15:40
S.06.05  Neurobiology of OCD: serotonin and beyond
Damiaan Denys, The Netherlands
 

14:00-16:05
S.07:    Interface track
Hot Topics 2
Chairs:  Jarmo Hietala, Finland
  David Morilak, USA
Room M

14:00
S.07.01  Significance of a genetically defined GABA-A receptor deficit on breathing behaviour: relevance to respiratory panic  Paper: S.07.01
Sophie Masneuf, Switzerland
 

14:15
S.07.02  Gene function in social and non-social memory  Paper: S.07.02
Hilgo Bruining, The Netherlands
 

14:30
S.07.03  Transforming growth factor-ß1 (TGF-ß1) signaling as a new pharmacological target against Aß-induced neurodegeneration  Paper: S.07.03
Filippo Caraci, Italy
 

14:45
S.07.04  Progesterone and estradiol plasma levels modulate serotonin-1A binding in the human brain  Paper: S.07.04
Christoph Spindelegger, Austria
 

15:00
S.07.05  Proline affects brain function in 22q11DS children with the low-activity COMT158 allele  Paper: S.07.05
Jacob Vorstman, The Netherlands
 

15:15
S.07.06  Triple dissociation of serotonergic influence on motivational behaviour under positive, negative and neutral mood  Paper: S.07.06
Oliver Robinson, United Kingdom
 

15:30
S.07.07  Seven days of citalopram reduces sensitivity to negative appraisal in a probabilistic learning task  Paper: S.07.07
Michael Browning, United Kingdom
 

15:45
S.07.08  Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processing  Paper: S.07.08
Susannah Murphy, United Kingdom
 

14:00-16:05
S.08:    Preclinical track
Cannabinoid CB1 and CB2 receptors: a new target for the treatment of neurological and psychiatric disorders
Chairs:  Stefan Borgwardt, Switzerland
  Alexandra Eva Sulcová, Czech Republic
Room F

14:00
S.08.01  The pharmacology of the cannabinoid system - an overview  Paper: S.08.01
Christopher Fowler, Sweden
 

14:25
S.08.02  The therapeutic potential of drugs that target the endogenous cannabinoid system  Paper: S.08.02
Roger G. Pertwee, United Kingdom
 

14:50
S.08.03  Neuroprotective effects of CB2 receptors  Paper: S.08.03
Javier Fernandez-Ruiz, Spain
 

15:15
S.08.04  Cannabidiol as antipsychotic  Paper: S.08.04
F. Markus Leweke, Germany
 

15:40
S.08.05  Role of the endocannabinoid system in pain and addiction
Rafael Maldonado, Spain
 

Scientific café